EA199800816A1 - Способы лечения и профилактики интерстициального цистита - Google Patents

Способы лечения и профилактики интерстициального цистита

Info

Publication number
EA199800816A1
EA199800816A1 EA199800816A EA199800816A EA199800816A1 EA 199800816 A1 EA199800816 A1 EA 199800816A1 EA 199800816 A EA199800816 A EA 199800816A EA 199800816 A EA199800816 A EA 199800816A EA 199800816 A1 EA199800816 A1 EA 199800816A1
Authority
EA
Eurasian Patent Office
Prior art keywords
interstitial cystitis
prevention
methods
treatment
duloxetine
Prior art date
Application number
EA199800816A
Other languages
English (en)
Other versions
EA001325B1 (ru
Inventor
Смрити Йенгар
Марк А. Мюльхаузер
Карл Б. Тор
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA199800816A1 publication Critical patent/EA199800816A1/ru
Publication of EA001325B1 publication Critical patent/EA001325B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Threshing Machine Elements (AREA)
  • Processing Of Meat And Fish (AREA)
  • Nozzles (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pistons, Piston Rings, And Cylinders (AREA)
  • Transplanting Machines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heat Treatment Of Articles (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)

Abstract

В этом изобретении представлены способы лечения или профилактики интерстициального цистита или уретрального синдрома у млекопитающих, которые заключаются в воздействии на нуждающееся в этом млекопитающее эффективным количеством дулоксетина.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199800816A 1996-03-11 1997-03-07 Способы лечения и профилактики интерстициального цистита EA001325B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1315796P 1996-03-11 1996-03-11
PCT/US1997/003410 WO1997033880A1 (en) 1996-03-11 1997-03-07 Methods of treating or preventing interstitial cystitis

Publications (2)

Publication Number Publication Date
EA199800816A1 true EA199800816A1 (ru) 1999-02-25
EA001325B1 EA001325B1 (ru) 2001-02-26

Family

ID=21758595

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800816A EA001325B1 (ru) 1996-03-11 1997-03-07 Способы лечения и профилактики интерстициального цистита

Country Status (23)

Country Link
EP (1) EP0888330B1 (ru)
JP (1) JP2000506863A (ru)
KR (1) KR19990087671A (ru)
CN (1) CN1217721A (ru)
AT (1) ATE239467T1 (ru)
AU (1) AU730448B2 (ru)
BR (1) BR9708027A (ru)
CA (1) CA2250288A1 (ru)
CZ (1) CZ287798A3 (ru)
DE (1) DE69721747T2 (ru)
DK (1) DK0888330T3 (ru)
EA (1) EA001325B1 (ru)
ES (1) ES2197993T3 (ru)
HU (1) HUP9902884A3 (ru)
IL (1) IL126159A (ru)
NO (1) NO984160D0 (ru)
NZ (1) NZ331811A (ru)
PL (1) PL328959A1 (ru)
PT (1) PT888330E (ru)
RO (1) RO117296B1 (ru)
UA (1) UA62926C2 (ru)
WO (1) WO1997033880A1 (ru)
YU (1) YU39598A (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1149991C (zh) 1998-09-15 2004-05-19 伊莱利利公司 持久性疼痛的治疗
EP1383495A1 (en) * 2001-03-29 2004-01-28 Eli Lilly And Company Duloxetine for treatment of hot flashes
AU2003225837B2 (en) * 2002-03-15 2008-11-06 Forest Laboratories Holdings Limited NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
DE10247689A1 (de) * 2002-10-12 2004-04-22 Martin Rahe Implantat in der Harnblase
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
US20100285123A1 (en) * 2005-06-20 2010-11-11 Rudresha Korlakunte Virupakshalah Prasad Controlled Release Dosage Formulation of Duloxetine
WO2008077939A2 (en) * 2006-12-27 2008-07-03 Lek Pharmaceuticals D.D. Duloxetine composition
EP2018860A1 (en) * 2007-07-16 2009-01-28 LEK Pharmaceuticals D.D. Duloxetine composition
EP1938840A1 (en) * 2006-12-27 2008-07-02 LEK Pharmaceuticals D.D. Duloxetine composition
WO2009066181A2 (en) * 2007-07-09 2009-05-28 Combino Pharm, S.L. Oral delayed-release duloxentine hydrochloride pellets
RU2719929C1 (ru) * 2018-12-17 2020-04-23 Юрий Анатольевич Игнашов Способ выбора лечения женщин с синдромом болезненного мочевого пузыря

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US574474A (en) * 1897-01-05 Course-indicating apparatus
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence

Also Published As

Publication number Publication date
ES2197993T3 (es) 2004-01-16
HUP9902884A3 (en) 2000-12-28
AU730448B2 (en) 2001-03-08
NO984160L (no) 1998-09-10
KR19990087671A (ko) 1999-12-27
IL126159A0 (en) 1999-05-09
NO984160D0 (no) 1998-09-10
BR9708027A (pt) 1999-08-03
YU39598A (sh) 1999-09-27
NZ331811A (en) 2001-04-27
CZ287798A3 (cs) 1999-05-12
PL328959A1 (en) 1999-03-01
CN1217721A (zh) 1999-05-26
RO117296B1 (ro) 2002-01-30
HUP9902884A2 (en) 2000-07-28
JP2000506863A (ja) 2000-06-06
DE69721747T2 (de) 2004-04-01
EP0888330A4 (en) 1999-04-07
DE69721747D1 (de) 2003-06-12
UA62926C2 (en) 2004-01-15
CA2250288A1 (en) 1997-09-18
PT888330E (pt) 2003-09-30
EP0888330B1 (en) 2003-05-07
ATE239467T1 (de) 2003-05-15
IL126159A (en) 2003-01-12
EP0888330A1 (en) 1999-01-07
EA001325B1 (ru) 2001-02-26
DK0888330T3 (da) 2003-09-01
AU2196297A (en) 1997-10-01
WO1997033880A1 (en) 1997-09-18

Similar Documents

Publication Publication Date Title
EA199800667A1 (ru) Новые фенантридины
EA199800626A1 (ru) Применение агониста ppar-гамма для лечения синдрома х
KR930703001A (ko) 전신 홍반성낭창의 치료방법
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
EA199800104A1 (ru) Способ лечения диабета
EA199900324A1 (ru) Комбинированная терапия для лечения психозов
EA199800857A1 (ru) Композиция для снятия боли и способ снятия боли
EA200000351A1 (ru) Лечение кондуктивных нарушений
EA200000349A1 (ru) Способ лечения оппозиционного расстройства
DK0772451T3 (da) Behandling af type II-diabetes mellitus med amylin-agonister
EA199800816A1 (ru) Способы лечения и профилактики интерстициального цистита
EA199800764A1 (ru) Способ лечения или предупреждения макулярного отека или возрастной макулярной дистрофии
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
EA199800821A1 (ru) Способ лечения аутизма
EA199800822A1 (ru) Способ лечения избыточной агрессии
DE69823739D1 (de) Glycin zur Vorbeugung oder Behandlung von Transplantatabstossungen
NO20012849D0 (no) Ny terapeutisk anvendelse for hepariner med lav molekylvekt
GT199900039A (es) Combinaciones de estatina-inhibidor de mmp.
DK0984787T3 (da) Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer
EA200001105A1 (ru) 10-камфорсульфонат пароксетина для лечения нарушений цнс
EA199800818A1 (ru) Способ лечения бессонницы
PT1017377E (pt) Utilizacao de 2-aminotetralinas 6,7-substituidas para o tratamento de condicoes inflamatorias mediadas por citoquina
DE69910608D1 (de) Neue therapeutische verwendung von 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU